Postcode lottery in ADHD diagnoses means middle classes drive a surge in prescriptions - Experts have warned that wealthier ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Despite decades of research, these ADHD myths still affect how people understand attention and behavior.

For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Study shows a developmental lag in a certain brain area in kids with ADHD. Nov. 12, 2007— -- Kids with attention deficit hyperactivity disorder lag three years behind their peers when it comes to ...

With an expiration date still more than a year away, here's what the latest details reveal.

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

Emotional outbursts are a core feature of ADHD, not bad behaviour. A paediatric neurologist explains why children with ADHD ...